Biotech rivalry: Heritage favors Bay Area, but is Boston the future?

(San Francisco Business Times subscription required.)

If South San Francisco’s Oyster Point Boulevard is the gateway to biotech’s birthplace, One Kendall Square in Cambridge may be the highway to the industry’s future.

With increasing amounts of seed, startup and early-stage venture cash, a $10 billion state program and a mixture of biotech startups, mature Big Pharma companies and academic interests within walking distance of each other, the Boston area is surging.